The company has not filed an annual or quarterly report since its Q2 FY2023 10-Q, filed May 2, 2023. Its latest SEC filing is a SC 13G/A from Feb 1, 2024.
10-Q for Q2 FY2023, filed May 2, 2023
The sections below describe the company as of the FY2022 annual report.
Provides water and wastewater treatment systems, technologies, and services for industrial, commercial, and municipal customers.
10-K for FY2022, filed Nov 16, 2022Through our operating subsidiaries (collectively referred to herein as “the Company,” “Evoqua,” “we,” “us,” or “our”), Evoqua provides a…View ↗
We provide solutions across the entire water cycle. The water cycle begins with influent water, which is sourced from rivers, lakes, and…View ↗
Our ISS segment provides application-specific solutions and full lifecycle services to treat process water, utility water, and wastewater…View ↗
Our APT segment sells differentiated and scalable products and technologies to a diverse set of water treatment system integrators and end…View ↗
Customers buy water-treatment products and equipment, with product sales tied to shipment or delivery. Evoqua also provides short-term services as performed and longer-term services over the agreement; customized projects generally use milestone billings.
10-K for FY2022, filed Nov 16, 2022
$1.7B
10-K for FY2022, filed Nov 17, 2022
$1.7B ↗
Industrial, commercial, and municipal end users buy water-treatment systems and services directly; OEMs, system integrators, distributors, and engineering firms buy products through indirect channels.
10-K for FY2022, filed Nov 16, 2022Our customers span a diverse range of end markets, including life sciences, light and general industry, power, microelectronics, chemical…View ↗
Our ISS segment markets its offerings through a direct sales and service team, which is organized geographically and by end market and is…View ↗
Our APT segment markets its offerings primarily through indirect channels to serve the global market or through our ISS segment’s sales…View ↗
Yes. It kept 4 cents of every revenue dollar as net income in FY2022 and turned 6 cents into free cash flow.
10-K for FY2022, filed Nov 17, 2022
$104MView ↗
10-K for FY2022, filed Nov 17, 2022
$72.2MView ↗
10-K for FY2022, filed Nov 17, 2022
$99.4MView ↗
8-K, filed May 24, 2023
Merger ConsiderationView ↗
8-K, filed May 23, 2023
On May 23, 2023, the Company announced that the Company and Parent have received all regulatory approvals required to consummate the…View ↗
8-K, filed Jan 23, 2023
On January 22, 2023, Evoqua Water Technologies Corp., a Delaware corporation (the “Company”), entered into an Agreement and Plan of Merger…View ↗
Grew. Revenue grew 30% in 4 years, from $1.3B in FY2018 to $1.7B in FY2022, about 7% a year.
Medical water treatment
The latest report adds Mar Cor's hemodialysis water equipment and services and says the acquisition expands Evoqua's reach into healthcare; the older report describes water-treatment systems and technologies for industrial, commercial, and municipal uses.
10-K for Q4 FY2019, filed Nov 25, 2019 10-K for FY2022, filed Nov 16, 2022Evoqua Water Technologies is a leading provider of mission critical water treatment solutions, offering services, systems and technologies…View ↗
On January 3, 2022, we acquired the renal business historically operated by Mar Cor Purification, Inc. and Cantel Medical LLC, subsidiaries…View ↗
Loading...
